Citation Impact
Citing Papers
Tumor Vaccines Expressing Flt3 Ligand Synergize with CTLA-4 Blockade to Reject Preimplanted Tumors
2009 StandoutNobel
Guidelines for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack
2014 Standout
Risk Factors for Venous Thromboembolism
2003 Standout
Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet
2009 Standout
Platelet associated immunoglobulins in primary biliary cirrhosis: a cause of thrombocytopenia?
1985
Differential Development of Murine Dendritic Cells by GM-CSF versus Flt3 Ligand Has Implications for Inflammation and Trafficking
2007
Infective Endocarditis in Adults: Diagnosis, Antimicrobial Therapy, and Management of Complications
2015 Standout
Sialic Acids in Molecular and Cellular Interactions
1997
Increased Thrombopoiesis and Platelet Activation in Hantavirus-Infected Patients
2015 StandoutNobel
Chronic Myeloproliferative Disorders
2003
A Clinical Trial of Vena Caval Filters in the Prevention of Pulmonary Embolism in Patients with Proximal Deep-Vein Thrombosis
1998 Standout
Model for the regulation of platelet volume and responsiveness by the trans‐membrane Na+/K+‐pump
1992
Aspirin as an Antiplatelet Drug
1994
Laboratory Testing for Heparin-Induced Thrombocytopenia
2000
Recurrence of venous thromboembolism in patients with familial thrombophilia
1997
The presence of infection-related antiphospholipid antibodies in infective endocarditis determines a major risk factor for embolic events
1999
Nanoparticle therapeutics: an emerging treatment modality for cancer
2008 Standout
Regression of Metastatic Renal-Cell Carcinoma after Nonmyeloablative Allogeneic Peripheral-Blood Stem-Cell Transplantation
2000 Standout
Malignancies, Prothrombotic Mutations, and the Risk of Venous Thrombosis
2005 Standout
Unexplained Pulmonary Hypertension in Chronic Myeloproliferative Disorders
2001
Early Phase I/II Trials with Gemtuzumab Ozogamicin (Mylotarg®) in Acute Myeloid Leukemia
2002
Temporal Aspects of Heparin-Induced Thrombocytopenia
2001 Standout
Current outcome of portal vein thrombosis in adults: Risk and benefit of anticoagulant therapy
2001
Microbial Stimulation Fully Differentiates Monocytes to DC-SIGN/CD209+ Dendritic Cells for Immune T Cell Areas
2010 StandoutNobel
Antithrombotic Therapy for VTE Disease
2012 Standout
Pulmonary hypertension in polycythemia vera
1994
Studies of the platelet fibrinogen receptor in Glanzmann patients and uremic patients
1992 StandoutNobel
The ATP-gated P2X1 Receptor Plays a Pivotal Role in Activation of Aspirin-treated Platelets by Thrombin and Epinephrine
2008 StandoutNobel
Immune Thrombocytopenic Purpura
2002 Standout
Cerebral Sinovenous Thrombosis in Children
2001 Standout
Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders
2005 Standout
Updated Clinical Classification of Pulmonary Hypertension
2013 Standout
Prevention of Venous Thromboembolism
2004 Standout
The clinical impact of glycobiology: targeting selectins, Siglecs and mammalian glycans
2021 StandoutNobel
Prostaglandin Endoperoxide H Synthases (Cyclooxygenases)-1 and −2
1996 Standout
Genomic and Epigenomic Landscapes of Adult De Novo Acute Myeloid Leukemia
2013 Standout
The Incidence of Recurrent Venous Thromboembolism After Treatment With Vitamin K Antagonists in Relation to Time Since First Event
2003
The Sialoadhesins ? A family of sialic acid-dependent cellular recognition molecules within the immunoglobulin superfamily
1996
Impaired Platelet Binding of Fibrinogen Due to a Lower Number of GPIIB/IIIA Receptors in Polycythemia Vera
1998 StandoutNobel
Efficacy and Safety of Recombinant Human Activated Protein C for Severe Sepsis
2001 Standout
Analysis of prognostic factors for the outcome of marrow transplantation or further chemotherapy for patients with acute nonlymphocytic leukemia in first remission.
1989 StandoutNobel
Pretreatment cytogenetic abnormalities are predictive of induction success, cumulative incidence of relapse, and overall survival in adult patients with de novo acute myeloid leukemia: results from Cancer and Leukemia Group B (CALGB 8461)
2002
Prothrombotic Disorders in Infants and Children With Cerebral Thromboembolism
1998
2 The histopathology of chronic myeloproliferative diseases
1998
Mortality Associated With Influenza and Respiratory Syncytial Virus in the United States
2003 Standout
Platelet autoantibodies in patients with chronic liver disease
1995
Complications of Femoral and Subclavian Venous Catheterization in Critically Ill Patients<SUBTITLE>A Randomized Controlled Trial</SUBTITLE>
2001 Standout
A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera
2005 StandoutNature
A Gain-of-Function Mutation of JAK2 in Myeloproliferative Disorders
2005 Standout
Efficacy and Safety of Low-Dose Aspirin in Polycythemia Vera
2004
Mechanisms of thrombogenesis in atrial fibrillation: Virchow's triad revisited
2009 Standout
Von Willebrand factor, fibrinogen, and soluble P-selectin levels after mitral valve replacement versus mitral valve repair
2000
Impact of cytogenetics on outcome of matched unrelated donor hematopoietic stem cell transplantation for acute myeloid leukemia in first or second complete remission
2007
Revised Recommendations of the International Working Group for Diagnosis, Standardization of Response Criteria, Treatment Outcomes, and Reporting Standards for Therapeutic Trials in Acute Myeloid Leukemia
2003 Standout
Venous thromboembolic complications (VTE) in children: first analyses of the Canadian Registry of VTE
1994
Demystifying the development of dendritic cell subtypes, a little
2008
Inherited thrombophilia: pathogenesis, clinical syndromes, and management [see comments]
1996
Maturation of the hemostatic system during childhood
1992 Standout
Studies of Fibrinogen Binding to Platelets by Flow Cytometry: An Improved Method for Studies of Platelet Activation
1992 StandoutNobel
Cyclooxygenases: Structural, Cellular, and Molecular Biology
2000 Standout
Primary Biliary Cirrhosis
1987 Standout
Approval summary: gemtuzumab ozogamicin in relapsed acute myeloid leukemia.
2001
Lectins: Carbohydrate-Specific Proteins That Mediate Cellular Recognition
1998 Standout
A common genetic variation in the 3'-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis
1996 Standout
Comparative Analysis of Haemostatic Proteinases: Structural Aspects of Thrombin, Factor Xa, Factor IXa and Protein C
1997
Respiratory Syncytial Virus Infection in Adults
2000
Nonmyeloablative Stem Cell Transplantation and Cell Therapy as an Alternative to Conventional Bone Marrow Transplantation With Lethal Cytoreduction for the Treatment of Malignant and Nonmalignant Hematologic Diseases
1998 Standout
Drug Delivery Systems: Entering the Mainstream
2004 StandoutScience
Polycythemia vera: myths, mechanisms, and management
2002
Recombinant human protein C, protein S and thrombomodulin as antithrombotics
1994
The Epidemiology of Venous Thromboembolism
2003 Standout
Intraperitoneal Cisplatin and Paclitaxel in Ovarian Cancer
2006 Standout
Engraftment of Allogeneic Hematopoietic Progenitor Cells With Purine Analog-Containing Chemotherapy: Harnessing Graft-Versus-Leukemia Without Myeloablative Therapy
1997
Decoding the Patterns of Self and Nonself by the Innate Immune System
2002 StandoutScience
Respiratory Syncytial Virus Infection in Adults
2000
Management of Deep Vein Thrombosis and Pulmonary Embolism
1996
Relationship of serum lactate dehydrogenase level with first remission length in adult acute lymphocytic leukaemia
1987
Functional Significance of Cell Volume Regulatory Mechanisms
1998 Standout
Inherited Prothrombotic Conditions and Premature Ischemic Stroke
1999
Venous thrombosis: a multicausal disease
1999 Standout
The World Health Organization (WHO) classification of the myeloid neoplasms
2002 Standout
Thrombocytosis: Diagnostic Evaluation, Thrombotic Risk Stratification, and Risk-Based Management Strategies
2011
Intraperitoneal treatment and dose-intense therapy in ovarian cancer
1999
Antibody to Langerin/CD207 localizes large numbers of CD8α + dendritic cells to the marginal zone of mouse spleen
2009 StandoutNobel
Development of the human coagulation system in the healthy premature infant
1988
Irreversible Inhibitors of Serine, Cysteine, and Threonine Proteases
2002 Standout
Nonmyeloablative Stem Cell Transplantation and Cell Therapy as an Alternative to Conventional Bone Marrow Transplantation With Lethal Cytoreduction for the Treatment of Malignant and Nonmalignant Hematologic Diseases
1998 Standout
Works of B Bizzi being referenced
Very high-dose chemotherapy with autologous peripheral stem cell support in advanced ovarian cancer
1995
Further investigations on the expression of HLA‐DR, CD33 and CD13 surface antigens in purified bone marrow and peripheral blood CD34± haematopoietic progenitor cells
1993
Mesenteric vein thrombosis in protein S congenital deficiency
1990
Respiratory syncytial virus infection in bone marrow transplantation: a case report (syncytial virus infection).
1990
The linkage between binding of the C-terminal domain of hirudin and amidase activity in human α-thrombin
1993
Replacement therapy with purified concentrate of protein c in homozygous or heterozygous patients
1993
Hematological Causes of Venous Thrombosis in Young People: High Incidence of Myeloproliferative Disorder as Underlying Disease in Patients with Splanchnic Venous Thrombosis
1992
Clinical Manifestations and Management of Inherited Thrombophilia: Retrospective Analysis and Follow-up after Diagnosis of 238 Patients with Congenital Deficiency of Antithrombin III, Protein C, Protein S
1994
Platelet‐Associated IgG in Acute and Chronic Hepatic Diseases
1981
Increased platelet-fibrinogen affinity in patients with myeloproliferative disorders [see comments]
1988
Prognostic factors of patients with acute myeloid leukemia (AML) allografted in first complete remission: an analysis of the EORTC-GIMEMA AML 8A trial. The European Organization for Research and Treatment of Cancer (EORTC) and the Gruppo Italiano Malattie Ematologiche Maligne dell' Adulto (GIMEMA) Leukemia Cooperative Groups.
1996
Increased thromboxane biosynthesis in patients with polycythemia vera: evidence for aspirin-suppressible platelet activation in vivo [see comments]
1992
Serum lactate dehydrogenase isoenzyme pattern in acute transformation of chronic granulocytic leukemia.
1986
Antithrombin III Pescara: a defective AT III variant with no alterations of plasma crossed immunoelectrophoresis, but with an abnormal crossed immunoelectrofocusing pattern
1987
Megathrombocytes, Platelet Regeneration Time and Platelet-Associated IgG in Idiopathic Thrombocytopenic Purpura and in Thrombocytopenia Associated with Chronic Liver Disease
1981
Antithrombin III in Full-Term and Pre-Term Newborn Infants : Three Cases of Neonatal Diagnosis of AT III Congenital Defect
1987
Replacement Therapy with a Purified Protein C Concentrate during Initiation of Oral Anticoagulation in Severe Protein C Congenital Deficiency
1993
Increased thromboxane biosynthesis in patients with polycythemia vera: evidence for aspirin-suppressible platelet activation in vivo [see comments]
1992
Management of Pregnancy in Women with Antithrombin III Congenital Defect: Report of Four Cases
1988
[The factor VIII complex in atherosclerosis].
1982
Thrombotic Risk during Pregnancy and Puerperium in Women with APC-Resistance – Effective Subcutaneous Heparin Prophylaxis in a Pregnant Patient
1995
Autologous stem cell transplantation: sequential production of hematopoietic cytokines underlying granulocyte recovery.
1993
Severe Deep Vein Thrombosis in a 2-Year-Old Child with Protein S Deficiency
1987